These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6347618)

  • 41. Comparison of cinoxacin and nalidixic acid in patients with cystitis.
    Paulson DF
    Urology; 1982 Aug; 20(2):138-40. PubMed ID: 7051507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Treatment of postoperative urinary infections in obstetrics and gynecology with cinoxacin].
    Bardi M; Manzoni A
    Clin Ter; 1988 Nov; 127(3):185-8. PubMed ID: 2976355
    [No Abstract]   [Full Text] [Related]  

  • 43. [Study of clinical efficacy and safety of long-term cinoxacin therapy of chronic urogenital organ infection].
    Hayashi Y; Terao E; Yamasaki I
    Hinyokika Kiyo; 1987 May; 33(5):799-805. PubMed ID: 3661347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Chronic prophylaxis of urinary tract infections in diabetic patients].
    Di Mauro M; Leonardi R; La Bella G; Iani P
    Minerva Med; 1990; 81(1-2):69-74. PubMed ID: 2314619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Preventive treatment of recurrent cystitis in women. Double-blind randomized study using cinoxacin and placebo].
    Martorana G; Giberti C; Damonte P
    Minerva Urol Nefrol; 1984; 36(1):43-9. PubMed ID: 6398519
    [No Abstract]   [Full Text] [Related]  

  • 46. Norfloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Holmes B; Brogden RN; Richards DM
    Drugs; 1985 Dec; 30(6):482-513. PubMed ID: 3908074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cinoxacin in therapy of urinary tract infections. Comparison of two dosage regimens.
    Cox CE; Simmons JR
    Urology; 1981 Jun; 17(6):539-41. PubMed ID: 7018051
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative study using norfloxacin and amoxycillin in the treatment of complicated urinary tract infections in geriatric patients.
    Leigh DA; Smith EC; Marriner J
    J Antimicrob Chemother; 1984 May; 13 Suppl B():79-83. PubMed ID: 6234279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cinoxacin in the treatment of acute urinary tract infections: an evaluation of efficacy and a comparison of dosage schedules.
    Rous SN
    J Urol; 1978 Aug; 120(2):196-7. PubMed ID: 671634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Influence of urinary pH on the pharmacokinetics of cinoxacin in humans and on antibacterial activity in vitro.
    Barbhaiya RH; Gerber AU; Craig WA; Welling PG
    Antimicrob Agents Chemother; 1982 Mar; 21(3):472-80. PubMed ID: 7103450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cinoxacin: pharmacokinetics and tolerance in patients with normal and impaired renal function.
    Maigaard S; Frimodt-Möller N; Welling PG; Madsen PO
    Antimicrob Agents Chemother; 1979 Sep; 16(3):411-6. PubMed ID: 507797
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA; Collen S; Andersson KE
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract]   [Full Text] [Related]  

  • 53. In vitro susceptibility of urinary isolates of Escherichia coli to cinoxacin.
    Barnham M; Gaya H
    J Antimicrob Chemother; 1979 Jul; 5(4):413-8. PubMed ID: 385579
    [No Abstract]   [Full Text] [Related]  

  • 54. Review of adverse reactions associated with cinoxacin and other drugs used to treat urinary tract infections.
    Burt RA
    Urology; 1984 Jan; 23(1):101-7. PubMed ID: 6362163
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term low dose cinoxacin therapy for the prevention of recurrent urinary tract infections.
    Landes RR
    J Urol; 1980 Jan; 123(1):47-50. PubMed ID: 7351723
    [No Abstract]   [Full Text] [Related]  

  • 56. ["In vitro" and "in vivo" antibacterial activity of a new synthetic antibiotic cinoxacin].
    Ravagnan G; Piccolomini R
    Boll Soc Ital Biol Sper; 1979 Jul; 55(14):1348-54. PubMed ID: 391252
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics of cinoxacin in elderly patients following repeated oral administration.
    Braga PC; Fraschini F; Scaglione F; Scarpazza G; Schiavi M; Ventura P
    Chemotherapy; 1987; 33(5):309-15. PubMed ID: 3665628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of cinoxacin in urinary tract infections.
    Panwalker AP; Giamarellou H; Jackson GG
    Antimicrob Agents Chemother; 1976 Mar; 9(3):502-5. PubMed ID: 1259405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro antimicrobial activity of cinoxacin against 2,968 clinical bacterial isolates.
    Jones RN; Fuchs PC
    Antimicrob Agents Chemother; 1976 Jul; 10(1):146-9. PubMed ID: 984747
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
    Vuye A
    Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.